Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 49 Records) |
| Query Trace: Disease and KEAP1[original query] |
|---|
| KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma. PloS one 2020 9 15 (9): e0238477. Saglam Ozlen, Tang Zhenya, Tang Guilin, Medeiros L Jeffrey, Toruner Gokce |
| Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancer. BMC cancer 2020 Sep 20 (1): 885. Jiang John, Adams Hans-Peter, Lange Maria, Siemann Sandra, Feldkamp Mirjam, McNamara Sylvie, Froehler Sebastian, Yaung Stephanie J, Yao Lijing, Balasubramanyam Aarthi, Tikoo Nalin, Ju Christine, Achenbach H Jost, Krügel Rainer, Palma John |
| KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden. Annals of oncology : official journal of the European Society for Medical Oncology 2020 Aug . Marinelli D, Mazzotta M, Scalera S, Terrenato I, Sperati F, D'Ambrosio L, Pallocca M, Corleone G, Krasniqi E, Pizzuti L, Barba M, Carpano S, Vici P, Filetti M, Giusti R, Vecchione A, Occhipinti M, Gelibter A, Botticelli A, De Nicola F, Ciuffreda L, Goeman F, Gallo E, Visca P, Pescarmona E, Fanciulli M, De Maria R, Marchetti P, Ciliberto G, Maugeri-Saccà |
| Genetic and epigenetic landscape of leukocyte infiltration identifies an immune prognosticator in lung adenocarcinoma. Cancer biomarkers : section A of Disease markers 2021 Jul . Khadirnaikar Seema, Chatterjee Annesha, Shukla Sudhanshu Kum |
| Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo. Cancer discovery 2021 3 11 (7): 1736-1753. Foggetti Giorgia, Li Chuan, Cai Hongchen, Hellyer Jessica A, Lin Wen-Yang, Ayeni Deborah, Hastings Katherine, Choi Jungmin, Wurtz Anna, Andrejka Laura, Maghini Dylan G, Rashleigh Nicholas, Levy Stellar, Homer Robert, Gettinger Scott N, Diehn Maximilian, Wakelee Heather A, Petrov Dmitri A, Winslow Monte M, Politi Kateri |
| Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation. Oncoimmunology 2021 2 10 (1): 1865670. Nie Wei, Gan Lu, Wang Xin, Gu Kai, Qian Fang-Fei, Hu Min-Juan, Zhang Ding, Chen Shi-Qing, Lu Jun, Cao Shu-Hui, Li Jing-Wen, Wang Yue, Zhang Bo, Wang Shu-Yuan, Li Chang-Hui, Yang Ping, Xu Mi-Die, Zhang Xue-Yan, Zhong Hua, Han Bao-H |
| Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer. Clinical lung cancer 2021 Oct . Hellyer Jessica A, White Maya N, Gardner Rebecca M, Cunanan Kristen, Padda Sukhmani K, Das Millie, Ramchandran Kavitha, Neal Joel W, Wakelee Heather |
| Comprehensive Analysis of TP53 and KEAP1 Mutations and Their Impact on Survival in Localized- and Advanced-Stage NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 10 17 (1): 76-88. Saleh Mohamed Mahde, Scheffler Matthias, Merkelbach-Bruse Sabine, Scheel Andreas Hans, Ulmer Bastian, Wolf Jürgen, Buettner Reinha |
| Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. Free radical biology & medicine 2021 Oct 177 58-71. Delgobo Marina, Gonçalves Rosângela Mayer, Delazeri Marco Antônio, Falchetti Marcelo, Zandoná Alessandro, Nascimento das Neves Raquel, Almeida Karoline, Fagundes Adriane Cristina, Gelain Daniel Pens, Fracasso João Isidro, Macêdo Guilherme Baroni de, Priori Leonardo, Bassani Nicklas, Bishop Alexander James Roy, Forcelini Cassiano Mateus, Moreira José Cláudio Fonseca, Zanotto-Filho Alf |
| Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy. Translational lung cancer research 2020 Dec 9 (6): 2367-2379. Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y |
| Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer. Journal of thoracic disease 2022 7 14 (6): 1772-1783. Malhotra Jyoti, Ryan Brid, Patel Malini, Chan Nancy, Guo Yanxiang, Aisner Joseph, Jabbour Salma K, Pine Shar |
| Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic Database. Clinical lung cancer 2022 6 23 (6): 487-497. Wu Yanyu, Yin Yu, Crossland Victoria, Vincent Sylvie, Paik Paul K, Lineberry Neil, Faller Douglas |
| Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study. Antioxidants (Basel, Switzerland) 2022 5 11 (5): . Renaud Cédric O, Ziros Panos G, Mathias Amandine, Pot Caroline, Sykiotis Gerasimos |
| Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 10 . Paik Paul K, Fan Pang-Dian, Qeriqi Besnik, Namakydoust Azadeh, Daly Bobby, Ahn Linda, Kim Rachel, Plodkowski Andrew, Ni Ai, Chang Jason, Fanaroff Rachel, Ladanyi Marc, de Stanchina Elisa, Rudin Charles |
| Computational Biological Modeling Identifies PD-(L)1 Immunotherapy Sensitivity Among Molecular Subgroups of KRAS-Mutated Non-Small-Cell Lung Cancer. JCO precision oncology 2022 1 5 153-162. Padda Sukhmani K, Aredo Jacqueline V, Vali Shireen, Singh Neeraj K, Vasista Sumanth M, Kumar Ansu, Neal Joel W, Abbasi Taher, Wakelee Heather |
| Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
| Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations. Cancer research and treatment 2023 9 . Boram Song, Seok Hyun Lee, Jeong Hwan Park, Kyung Chul Mo |
| GPX3 rs8177412 Polymorphism Modifies Risk of Upper Urothelial Tumors in Patients with Balkan Endemic Nephropathy. Medicina (Kaunas, Lithuania) 2023 8 59 (8): . Zana Radic Savic, Vesna Coric, Stojko Vidovic, Vanja Vidovic, Jelena Becarevic, Irina Milovac, Zorica Reljic, Bosa Mirjanic-Azaric, Ranko Skrbic, Radoslav Gajanin, Marija Matic, Tatjana Sim |
| A core Nrf2 gene set defined through comprehensive transcriptomic analysis predicts drug resistance and poor multi-cancer prognosis. bioRxiv : the preprint server for biology 2023 5 . George Luo, Harshita Kumar, Kristin Aldridge, Stevie Rieger, Ethan Jiang, Ernest R Chan, Ahmed Soliman, Haider Mahdi, John J Letter |
| Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC. Cancer discovery 2023 4 . Negrao Marcelo V, Araujo Haniel A, Lamberti Giuseppe, Cooper Alissa J, Akhave Neal S, Zhou Teng, Delasos Lukas, Hicks J Kevin, Aldea Mihaela, Minuti Gabriele, Hines Jacobi, Aredo Jacqueline V, Dennis Michael J, Chakrabarti Turja, Scott Susan C, Bironzo Paolo, Scheffler Matthias, Christopoulos Petros, Stenzinger Albrecht, Riess Jonathan W, Kim So Yeon, Goldberg Sarah B, Li Mingjia, Wang Qi, Qing Yun, Ni Ying, Do Minh Truong, Lee Richard, Ricciuti Biagio, Alessi Joao Victor, Wang Jing, Resuli Blerina, Landi Lorenza, Tseng Shu-Chi, Nishino Mizuki, Digumarthy Subba R, Rinsurongkawong Waree, Rinsurongkawong Vadeerat, Vaporciyan Ara A, Blumenschein George R, Zhang Jianjun, Owen Dwight H, Blakely Collin M, Mountzios Giannis, Shu Catherine A, Bestvina Christine M, Garassino Marina Chiara, Marrone Kristen A, Gray Jhanelle E, Patel Sandip Pravin, Cummings Amy L, Wakelee Heather A, Wolf Juergen, Scagliotti Giorgio Vittorio, Cappuzzo Federico, Barlesi Fabrice, Patil Pradnya D, Drusbosky Leylah, Gibbons Don L, Meric-Bernstam Funda, Lee J Jack, Heymach John V, Hong David S, Heist Rebecca S, Awad Mark M, Skoulidis Ferdinand |
| Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2023 2 . Rao Wen, Yang Lujie, Dai Nan, Zhang Liang, Liu Jie, Yang Bo, Li Mengxia, Shan Jinlu, Wang Qiushi, Wang Do |
| KEAP1/NRF2 Mutations in Stem Cells Define an Aggressive Subset of Head and Neck Cancer Patients Who Have a Poor Prognosis, Lung Metastasis, and Therapeutic Failure. Cancers 2023 10 15 (20): . Syed S Islam, Bedri Karakas, Abdelilah Aboussekhra, Abu Shadat M Nom |
| Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the NFE2L2/KEAP1 Polymorphisms in Regulating SARS-CoV-2 Infection. International journal of molecular sciences 2023 1 24 (1): . Soto María Elena, Fuentevilla-Álvarez Giovanny, Palacios-Chavarría Adrián, Vázquez Rafael Ricardo Valdez, Herrera-Bello Héctor, Moreno-Castañeda Lidia, Torres-Paz Yazmín Estela, González-Moyotl Nadia Janet, Pérez-Torres Idalia, Aisa-Alvarez Alfredo, Manzano-Pech Linaloe, Pérez-Torres Israel, Huesca-Gómez Claudia, Gamboa Ricar |
| Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab. JAMA network open 2023 1 6 (1): e2249591. Lebow Emily S, Shepherd Annemarie, Eichholz Jordan E, Offin Michael, Gelblum Daphna Y, Wu Abraham J, Simone Charles B, Schoenfeld Adam J, Jones David R, Rimner Andreas, Chaft Jamie E, Riaz Nadeem, Gomez Daniel R, Shaverdian Nar |
| Transcriptional phenocopies of deleterious KEAP1 mutations correlate with survival outcomes in lung cancer treated with immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 7 . Stefano Scalera, Biagio Ricciuti, Daniele Marinelli, Marco Mazzotta, Laura Cipriani, Giulia Bon, Giulia Schiavoni, Irene Terrenato, Alessandro Di Federico, Joao V Alessi, Maurizio Fanciulli, Ludovica Ciuffreda, Francesca De Nicola, Frauke Goeman, Giulio Caravagna, Daniele Santini, Ruggero De Maria, Federico Cappuzzo, Gennaro Ciliberto, Mariam Jamal-Hanjani, Mark M Awad, Nicholas McGranahan, Marcello Maugeri-Sac |
| Combining genomic biomarkers to guide immunotherapy in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 2 . Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voe |
| Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer. Cell 2024 12 . Mark Zucker, Maria A Perry, Samuel I Gould, Arielle Elkrief, Anton Safonov, Rohit Thummalapalli, Miika Mehine, Debyani Chakravarty, A Rose Brannon, Marc Ladanyi, Pedram Razavi, Mark T A Donoghue, Yonina R Murciano-Goroff, Kristiana Grigoriadis, Nicholas McGranahan, Mariam Jamal-Hanjani, Charles Swanton, Yuan Chen, Ronglai Shen, Sarat Chandarlapaty, David B Solit, Nikolaus Schultz, Michael F Berger, Jason Chang, Adam J Schoenfeld, Francisco J Sánchez-Rivera, Ed Reznik, Chaitanya Bandlamu |
| Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 12 . Li Guan, Pedro A Torres-Saavedra, Xiaobei Zhao, Michael B Major, Brittany J Holmes, Ngan K Nguyen, Parasakthy Kumaravelu, Tim Hodge, Maximilian Diehn, Jose P Zevallos, F Christopher Holsinger, Bahman Emami, Richard C Jordan, Michele C Hayward, Stephen M Sagar, William Morrison, Christopher Schultz, Jimmy J Caudell, Christopher U Jones, Scott V Bratman, Thomas J Galloway, Daniel J Ma, Sue S Yom, Mahesh Kudrimoti, Harold E Kim, Jonathan Harris, Quynh-Thu Le, D Neil Hay |
| Identification of Molecular Subtypes and Prognostic Traits Based on Chromosomal Instability Phenotype-Related Genes in Lung Adenocarcinoma. Cancers 2024 11 16 (22): . Youngsic Jeon, Kyung-Chul Choi, Young Nyun Park, Young-Joo K |
| Outcomes following KRAS inhibitor treatment in patients with KRAS-mutated solid tumors: A systematic review and meta-analysis. Pharmacological research 2024 1 200 107060. Qi-An Chen, Wei-Hao Lin, Xiao-Xiang Zhou, Zheng Cao, Xiao-Li Feng, Yi-Bo Gao, Jie |
- Page last reviewed:Feb 1, 2024
- Content source: